Revolution Medicines Inc
RVMDNASDAQStock · Data from SEC EDGAR 13F · Held by 11 of 87 tracked investors
Revolution Medicines Inc at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation15
- Growth–
- Profitability25
- Quality20
- Debt100
- Stability14
- ✓It has more cash than debt.
- ✓The analysts' average target is 39% above the price.
Is the stock expensive?
ExpensiveThe company has no earnings, so the P/E cannot be calculated.
- P/E
- –
- P/S
- –
- EV/EBITDA
- -22.7×
Is the company growing?
–Too few years to compare. Last year –.
Does it make money?
Loss-makingNet margin: 0.0%.
Is it financially healthy?
Yes- Cash
Earnings results
| Quarter | Reported | EPS | Analyst estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | 5 Aug 2026 | -2.34 | -1.93 | -21.2% |
| Mar 2026 | 6 May 2026 | -2.29 | -1.83 | -25.1% |
| Dec 2025 | 25 Feb 2026 | -1.86 | -1.56 | -19.2% |
| Sep 2025 | 5 Nov 2025 | -1.61 | -1.39 | -15.8% |
EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.
Chart RVMD
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
11SD Stanley Druckenmiller Duquesne Family Office | 1.44% |
LB Louis Bacon Moore Capital Management | 0.23% |
CA Cliff Asness AQR Capital Management | 0.08% |
JG Joel Greenblatt Gotham Asset Management | 0.05% |
Ns Norský státní fond Norges Bank | 0.04% |
Šn Švýcarská národní banka Swiss National Bank | 0.04% |
KG Ken Griffin Citadel Advisors | 0.01% |
SC Steven Cohen Point72 Asset Management | 0.01% |
IE Israel Englander Millennium Management | 0.01% |
KF Ken Fisher Fisher Investments | 0.01% |
RB Ron Baron Baron Capital | 0% |
Frequently asked questions
How much is Revolution Medicines Inc (RVMD) stock?
Revolution Medicines Inc shares trade at $186.22, +1.26% over the last trading day. The price is delayed.
What is the market cap of Revolution Medicines Inc?
The market cap of Revolution Medicines Inc is about $39.9B.
Which big investors hold Revolution Medicines Inc?
According to the latest 13F filings, 11 of 87 tracked investors hold Revolution Medicines Inc, for example Stanley Druckenmiller, Louis Bacon, Cliff Asness.
When will Revolution Medicines Inc report its next results?
The next earnings report of Revolution Medicines Inc is expected on 4 Nov 2026.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.